Concepedia

Stephen A. Beers

SA

Statistics

Publications

47

Citations

4.5K

H-Index

32

Active since

1997

Affiliations

University of Southampton(Current)

Southampton General Hospital

Cancer Research UK

University Hospital Southampton NHS Foundation Trust

BioInvent (Sweden)

Stephen A. Beers is an author at University of Southampton specializing in immunology, cancer immunotherapy, and cancer immunology.

ORCID

Publications per year

1997–2025

47

Publications

47

The Biological Activity of Human CD20 Monoclonal Antibodies Is Linked to Unique Epitopes on CD20

Jessica L. Teeling, Wendy J.M. Mackus, Luus Wiegman et al. · The Journal of Immunology · 2006 · 604 citations

, , +17

Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established Tumors

Frederick Arce Vargas, Andrew J.S. Furness, Isabelle Solomon et al. · Immunity · 2017 · 430 citations · Full text

, , +17

Antigenic modulation limits the efficacy of anti-CD20 antibodies: implications for antibody selection

Stephen A. Beers, Ruth R. French, H.T. Claude Chan et al. · Blood · 2010 · 330 citations

, , +16

Novel type II anti-CD20 monoclonal antibody (GA101) evokes homotypic adhesion and actin-dependent, lysosome-mediated cell death in B-cell malignancies

Waleed Alduaij, Andrei Ivanov, Jamie Honeychurch et al. · Blood · 2011 · 292 citations · Full text

, , +14

Fc gamma receptor IIb on target B cells promotes rituximab internalization and reduces clinical efficacy

Sean H. Lim, Andrew Vaughan, Margaret Ashton‐Key et al. · Blood · 2011 · 263 citations · Full text

, , +14

1–5 of 47